IMP-2552
IMP-2552 is a RAB27A/B inhibitor. IMP-2552 acts on the RAB27A/B effector protein-protein interaction, selectively modifying RAB27A/B-Cys123, but has no activity against RAB27A-Cys188. IMP-2552 can be used for the research of cancer.
For research use only. We do not sell to patients.
- CAS No.: 3129690-90-7
- Formula: C25H26N6O5S
- Molecular Weight:522.58
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
IMP-2552 (Compound 10) (2 h) potently inhibits the RAB27A-effector protein-protein interaction in a cell-free fluorescence polarization assay with an IC50 of 3.61 μM and a kinact/Ki of 32.1/M·s[1].
IMP-2552 (10 μM; 1 h) covalently and selectively modifies the Cys123 residue of recombinant RAB27A and RAB27B with equal potency against both active (GTP-bound) and inactive (GDP-bound) RAB27A, achieving 82.3% labeling of nRAB27A-Cys123 with minimal modification of Cys188[1].
IMP-2552 (10 μM; 2 h pre-incubation) stereoselectively engages endogenous RAB27A and RAB27B in MDA-MB-231 cells, competing for probe binding without affecting off-target proteins or inducing cytotoxicity[1].
IMP-2552 (10-20 μM; 14 h) disrupts the endogenous RAB27A-SLP2-A protein-protein interaction in MDA-MB-231 cells[1].
IMP-2552 (10 μM; 24 h) induces perinuclear melanosome clustering in melan-a mouse melanocytes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 3129690-90-7
-
Molecular Weight 522.58
-
Formula C25H26N6O5S
-
SMILES
O=C([C@H]1N(S(=O)(C2=CC=C(NC(C=C)=O)C=C2)=O)CCC1)NC3=CC=C(C(NC4=NN(C)C=C4)=O)C=C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Pull-down
The pull-down assay is an in vitro technique used to detect physical interactions between two or more proteins and an invaluable tool for confirming a predicted protein-protein interaction or identifying novel interacting partners. This method typically involves the use of affinity purification with various wash and elution steps.
-
Immunoprecipitation
Immunoprecipitation (IP) is an experimental method that uses the principle of antibody specific binding to purify and enrich target proteins.
-
Protocol for Bimolecular Fluorescence Complementation (BiFC) Assay
Bimolecular fluorescence complementation detects protein-protein proximity in living or fixed cells by fusing two candidate interaction partners to nonfluorescent N- and C-terminal fragments of a fluorescent protein; when the partners interact or remain close enough, the fluorescent fragments complement, mature, and generate a fluorescent signal at the site of the protein complex. The BiFC readout is fluorescence intensity and subcellular localization of the reconstituted fluorophore, which reflects formation or stabilization of a protein complex rather than direct biochemical binding kinetics; BiFC is therefore useful for mapping where interactions occur in cancer cells, neurons, macrophages, organoid-derived cells, or drug-screening systems, but results should be validated by independent assays such as co-IP or Western blot. BiFC signal formation is delayed by fluorophore maturation and can stabilize otherwise transient complexes, so it is not a real-time reversible interaction assay
-
Co-Immunoprecipitation
Co-immunoprecipitation technology can verify protein interaction based on the specific immune reaction between antibodies and antigens.
-
Protocol for Yeast Two-Hybrid (Y2H) Assay
The yeast two-hybrid assay detects binary protein-protein interactions by separating a transcription factor into a DNA-binding domain fused to a "bait" protein and a transcriptional activation domain fused to a "prey" protein; if bait and prey interact in yeast, the transcription factor is reconstituted and activates reporter genes such as HIS3, ADE2, lacZ, MEL1, or other selectable/readable reporters. The readout is yeast growth on selective medium and/or reporter activity, which reflects proximity-dependent transcriptional activation in the yeast nucleus rather than direct biochemical binding in the original mammalian, tumor, neuronal, macrophage, or organoid context. Because yeast two-hybrid can generate false positives and false negatives, interaction claims should be validated using independent assays such as co-immunoprecipitation, Western blot, immunofluorescence colocalization, BiFC, pull-down, or mammalian two-hybrid assays.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)